Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Trauma, Forgiveness, and Reconciliation Studies attracts global attention
2016-06-27

Description: Lerato Machetela  Tags: Lerato Machetela

Lerato Machetela is on her way to
Ghent University in Belgium where
she will spend 10 months working
alongside experts in the field of
historical trauma.
Photo: Eugene Seegers

Research excellence is one of the major driving forces at the core of the University of the Free State (UFS). This striving for academic distinction has found embodiment within Trauma, Forgiveness, and Reconciliation (TFR) Studies. Headed by Research Fellow and Senior Research Professor Pumla Gobodo-Madikizela, the research unit is raking in achievements consistently.

Cornell University Distinguished African Scholar Award
Leading by example, Prof Gobodo-Madikizela received the prestigious 2016 Distinguished African Scholar Award from Cornell University recently. Being honoured with this award affirms an unusual depth of knowledge and experience in a field related to the recipient’s own work. Through this award, Prof Gobodo-Madikizela is now also affiliated with the Institute for African Development and the Psychology Department at Cornell University.

Ghent University fellowship in historical trauma
Another member of TFR has caught international attention. Lerato Machetela – a PhD student at the research unit – received an invitation from scholars at Ghent University in Belgium. Machetela will leave in September, where she will spend ten months in Ghent with experts in the field of historical trauma. She will be affiliated to their university’s Cultural Memory Studies Initiative and the Psychology Department. When Machetela submitted her PhD proposal on transgenerational transmisison of trauma among the youth in Jagersfontein to the UFS Psychology Department panel, “it was hailed as a unique project, and a first for the department,” Prof Gobodo-Madikizela says.

Description: Naleli Morojele Tags: Naleli Morojele

Naleli Morojele conducting the research
in Rwanda that has formed the basis of
her new book, Women Political Leaders
in Rwanda and South Africa: Narratives
of Triumph and Loss.

Book explores triumph and loss of female political leaders
TFR cultivates thriving authors actively, the latest being Naleli Morojele, who is pursuing a PhD in the field of Political Studies. Soon, Morojele will be launching her book, Women Political Leaders in Rwanda and South Africa: Narratives of Triumph and Loss. Through the stories of significant female Rwandan and South African leaders, the reader gains insight into these women’s early-life experiences, struggles, and successes. Perhaps even more pertinently, Morojele’s book also exposes the ways in which gender inequality still works to smother their roles as citizens and politicians.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept